Life Science IP 2017 is a conference that provides an insight on how to navigate benefit areas within existing European IP frameworks, maximise the value of your organisation`s intellectual property, and find clarity after a series of curtailing decisions on innovation.
Topics
- The changing European patent landscape - from the European Commission, Gilead Sciences, the Presiding Judge of the Munich Regional Court and the UPC itself!
- Workshops highlighting only the information that is critical to you as an IP professional within a Life Sciences company
- Eligibility, the Early Certainty Programme, and licensing options from the EPO, Ablynx, and Bracco
